Skip to main content

ESKAPE Pathogens

Virulence, Resistance, and Management

  • 1st Edition - July 1, 2026
  • Latest edition
  • Editor: Karthikeyan Ramalingam
  • Language: English

ESKAPE Pathogens: Virulence, Resistance, and Management provides comprehensive coverage on ESKAPE pathogens, including their virulence mechanisms, resistance patterns, and challe… Read more

Early spring sale

Nurture your knowledge

Grow your expertise with up to 25% off trusted resources.

Description

ESKAPE Pathogens: Virulence, Resistance, and Management provides comprehensive coverage on ESKAPE pathogens, including their virulence mechanisms, resistance patterns, and challenges in their management. The book offers the latest information on ESKAPE pathogens' pathogenicity, mechanisms of antibiotic resistance, and innovative approaches to manage these pathogens. It explores recent advancements in the field of genomics, proteomics, and transcriptomics that could potentially provide valuable insights into the mechanisms and genetic basis of antibiotic resistance in ESKAPE pathogens. Finally, the book highlights the need for alternative treatment options and innovative management strategies to combat the emergence of multidrug-resistant strains.

This is a helpful resource to researchers, clinicians, educators, industry professionals, and advanced students interested in the latest research and strategies for combating multidrug-resistant pathogens.

Key features

  • Offers practical guidance on identifying and managing infections caused by ESKAPE pathogens, including diagnosis, treatment, and prevention
  • Discusses the latest research on management strategies to combat ESKAPE pathogens
  • Explores novel therapeutic approaches and prevention strategies for infections caused by ESKAPE pathogens

Readership

Researchers, clinicians, educators, and advanced students in the fields of microbiology, infectious diseases, immunology, and public health interested in the latest research and strategies for combating multidrug-resistant pathogens. professionals working in academia, government agencies, and the pharmaceutical industry who are involved in the development of new treatments and vaccines for infectious diseases caused by ESKAPE pathogens

Table of contents

1. Introduction to ESKAPE Pathogens

2. Mechanisms of Virulence in ESKAPE Pathogens

3. Antibiotic Resistance in ESKAPE Pathogens

4. Antimicrobial Compounds to Overcome ESKAPE Pathogens

5. Emerging Strategies in the Fight Against Colistin-Resistant ESKAPE Pathogens

6. Novel Approaches to Tackle Carbapenem-Resistant ESKAPE Pathogens

7. Mobile Genetic Elements and Antibiotic Resistance in ESKAPE Pathogens

8. Molecular Basis of Antimicrobial Resistance in Bacteria ESKAPE

9. Clinical Management and Diagnostic Methods of ESKAPE Infections

10. Host-pathogen Interactions in ESKAPE Infections- Related Infection Models

11. The Role of Biofilms in ESKAPE Pathogenesis and Antibiotic Resistance

12. Compounds for Antibiofilm Action Against ESKAPE Pathogens

13. Infection Control and Prevention Strategies for ESKAPE Pathogens

14. Novel Therapeutic Approaches for ESKAPE Pathogens

15. Role of Quorum Sensing in ESKAPE Pathogen Pathogenesis

16. Interactions between ESKAPE Pathogens and the Host Immune System

17. Epidemiology and Surveillance of ESKAPE Pathogens

18. Prospects and Challenges in Research and Management of ESKAPE Pathogens

Product details

  • Edition: 1
  • Latest edition
  • Published: July 1, 2026
  • Language: English

About the editor

KR

Karthikeyan Ramalingam

Karthikeyan Ramalingam is a highly accomplished academic and researcher with over 23 years of teaching experience. He currently serves as a Professor at B.S. Abdur Rahman Crescent Institute of Science and Technology, India, and also holds the positions of Dean of Student Affairs and Chief Proctor (Discipline) at the institute. He is also the CEO and Founder of Nano I Technology, a startup company that focuses on nanoemulsion and nanoparticle-based antimicrobial agents for ESKAPE pathogens, biofilm inhibitors, and bioactive venoms compound from marine sources. He has a PhD in Marine Biology from Annamalai University, India, and has held several postdoctoral positions as a Research Scientist at prestigious institutions such as the Naval Medical Research Unit-San Antonio, the University of Texas Health Science Center in San Antonio, Texas, USA and New York University (NYU), USA. Dr. Ramalingam's research expertise includes microbiology, ESKAPE pathogens, infectious diseases, and nanotechnology, with a focus on developing novel therapies for drug-resistant pathogens. He has published over 50+ research articles, and eight funded projects, and holds three patents. He is a member of several professional societies, including the American Society for Microbiology, the New York Academy of Sciences, and the Association of Microbiologists of India.

Affiliations and expertise
Professor, School of Life Sciences, Dean of Student Affairs & Chief Proctor, SA Crescent Institute of Science and Technology, Chennai, India